Incidence of invasive pneumococcal disease in Scotland, 1988-99

Epidemiology and Infection

Volumn 128, Issue 2, 2002, Pages 139-147

  Kyaw, M H ^a,c   Clarke, S ^b   Jones, I G ^c   Campbell, H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Scottish Meningococcus and Pneumococcus Reference Laboratory   (United Kingdom)

^c Scottish Centre for Infection and Environmental Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; ERYTHROMYCIN; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; POLICY; PREVALENCE; SEASONAL VARIATION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND; SEROTYPING; SEX FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036225445     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268801006586     Document Type: Article

References (52)

1. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. Bacteremia with Streptococcus pneumoniae: Implications for therapy and prevention
3. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995
4. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance 1995-1997
5. Antibiotic-resistant pneumococci
6. Clinical outcomes of bacteraemic pneumococcal pneumonia in the era of antibiotic resistance
7. Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: Implication for vaccine strategies
8. Pneumococcal vaccine
9. Bacterial meningitis in the United States in 1995
10. Invasive pneumococcal disease in England and Wales: Vaccination implications
11. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand
12. The epidemiology of invasive pneumococcal disease in Alaska 1986-1990: Ethnic differences and opportunities for prevention
13. High incidence rate of invasive pneumococcal disease in the White Mountain Apache population
14. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotics prophylaxis
15. Invasive pneumococcal disease in central Australia
16. Pneumococcal disease among children in a rural area of West Africa
17. Epidemiology of invasive pneumococcal disease in the Western region, The Gambia
18. Epidemiology of invasive childhood pneumococcal infections in Israel
19. Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country
20. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California
21. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland
22. Invasive pneumococcal infections: Incidence, predisposing factors and prognosis
23. Pneumococcal disease in Sweden: Experiences and current situation
24. Bacteraemic pneumococcal pneumonia in one American city: A 20-year longitudinal study 1978-1997
25. Pneumococcal bacteremia in Charleston County, South Carolina a decade later
26. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-1994
27. Serologically indicated pneumococcal respiratory infection in children
28. The epidemiology of pneumococcal infection in children in the developed world
29. Etiology of severe pneumonia in children in developing countries
30. The aetiology of pneumonia in malnourished and well-nourished Gambian children
31. The epidemiology of community-acquired pneumonia among hospitalised adults
32. A prospective hospital study of the etiology of community-acquired pneumonia
33. Invasive pneumococcal infection in South and West England
34. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution and the isolation of respiratory viruses
35. Pneumonia with special reference to pneumococcal lobar pneumonia
36. The epidemiology of penicillin resistance in Streptococcus pneumoniae
37. Antibiotic resistance in Streptococcus pneumoniae
38. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis
39. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centres for Disease Control and Prevention's Pneumococcal Sentinel System
40. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States
41. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics
42. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis
43. Carriage of multi-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center
44. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: Results of observational surveys in 1990 and 1995
45. Conjugate pneumococcal vaccine and antibiotic resistant Streptococcus pneumoniae and reduction of otitis morbidity
46. Evidence for the introduction of a multi-resistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s
47. Antimicrobial resistance with Streptococcus pneumoniae in the United States 1997-98
48. Emergence of drug resistant pneumococcal infections in the United States
49. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
50. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia
51. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children?